Search Results - "Oommen Jose, Aylin"
-
1
Immunogenicity and safety of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine in people living with and without HIV-1 infection: a randomised, controlled, phase 2A/2B trial
Published in The lancet HIV (01-05-2022)“…There is a paucity of data on COVID-19 vaccines in people living with HIV-1, who could be at increased risk of severe illness and death from COVID-19. We…”
Get full text
Journal Article -
2
Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant
Published in The New England journal of medicine (20-05-2021)“…A randomized, phase 2 trial compared the NVX-CoV2373 nanoparticle vaccine with placebo in participants in South Africa, including 30% who were seropositive at…”
Get full text
Journal Article -
3
Efficacy of primary series AZD1222 (ChAdOx1 nCoV-19) vaccination against SARS-CoV-2 variants of concern: Final analysis of a randomized, placebo-controlled, phase 1b/2 study in South African adults (COV005)
Published in Vaccine (26-05-2023)“…•COVID-19 vaccine efficacy (VE) varies against SARS-CoV-2 variants of concern.•We present a final VE analysis from a phase 1b/2 AZD1222 trial in South…”
Get full text
Journal Article